» Articles » PMID: 33251212

Osteochondral Injury, Management and Tissue Engineering Approaches

Overview
Specialty Cell Biology
Date 2020 Nov 30
PMID 33251212
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Osteochondral lesions (OL) are a common clinical problem for orthopedic surgeons worldwide and are associated with multiple clinical scenarios ranging from trauma to osteonecrosis. OL vary from chondral lesions in that they involve the subchondral bone and chondral surface, making their management more complex than an isolated chondral injury. Subchondral bone involvement allows for a natural healing response from the body as marrow elements are able to come into contact with the defect site. However, this repair is inadequate resulting in fibrous scar tissue. The second differentiating feature of OL is that damage to the subchondral bone has deleterious effects on the mechanical strength and nutritive capabilities to the chondral joint surface. The clinical solution must, therefore, address both the articular cartilage as well as the subchondral bone beneath it to restore and preserve joint health. Both cartilage and subchondral bone have distinctive functional requirements and therefore their physical and biological characteristics are very much dissimilar, yet they must work together as one unit for ideal joint functioning. In the past, the obvious solution was autologous graft transfer, where an osteochondral bone plug was harvested from a non-weight bearing portion of the joint and implanted into the defect site. Allografts have been utilized similarly to eliminate the donor site morbidity associated with autologous techniques and overall results have been good but both techniques have their drawbacks and limitations. Tissue engineering has thus been an attractive option to create multiphasic scaffolds and implants. Biphasic and triphasic implants have been under explored and have both a chondral and subchondral component with an interface between the two to deliver an implant which is biocompatible and emulates the osteochondral unit as a whole. It has been a challenge to develop such implants and many manufacturing techniques have been utilized to bring together two unalike materials and combine them with cellular therapies. We summarize the functions of the osteochondral unit and describe the currently available management techniques under study.

Citing Articles

Patellar Non-Traumatic Pathologies: A Pictorial Review of Radiologic Findings.

Masroori Z, Haseli S, Abbaspour E, Pouramini A, Azhideh A, Fathi M Diagnostics (Basel). 2025; 14(24.

PMID: 39767189 PMC: 11675855. DOI: 10.3390/diagnostics14242828.


Application of polydopamine-modified triphasic PLA/PCL-PLGA/Mg(OH)-velvet antler polypeptides scaffold loaded with fibrocartilage stem cells for the repair of osteochondral defects.

Cheng R, Xie T, Ma W, Deng P, Liu C, Hong Y Front Bioeng Biotechnol. 2024; 12:1460623.

PMID: 39372430 PMC: 11450761. DOI: 10.3389/fbioe.2024.1460623.


Drug-Loaded Bioscaffolds for Osteochondral Regeneration.

Tong Y, Yuan J, Li Z, Deng C, Cheng Y Pharmaceutics. 2024; 16(8).

PMID: 39204440 PMC: 11360256. DOI: 10.3390/pharmaceutics16081095.


T1ρ relaxation mapping in osteochondral lesions of the talus: a non-invasive biomarker for altered biomechanical properties of hyaline cartilage?.

Bogner B, Wenning M, Jungmann P, Reisert M, Lange T, Tennstedt M Eur Radiol Exp. 2024; 8(1):83.

PMID: 39046607 PMC: 11269556. DOI: 10.1186/s41747-024-00488-4.


Osteochondral organoids: current advances, applications, and upcoming challenges.

Faeed M, Ghiasvand M, Fareghzadeh B, Taghiyar L Stem Cell Res Ther. 2024; 15(1):183.

PMID: 38902814 PMC: 11191177. DOI: 10.1186/s13287-024-03790-5.


References
1.
Johnstone B, Hering T, Caplan A, Goldberg V, Yoo J . In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998; 238(1):265-72. DOI: 10.1006/excr.1997.3858. View

2.
Kon E, Filardo G, Robinson D, Eisman J, Levy A, Zaslav K . Osteochondral regeneration using a novel aragonite-hyaluronate bi-phasic scaffold in a goat model. Knee Surg Sports Traumatol Arthrosc. 2013; 22(6):1452-64. DOI: 10.1007/s00167-013-2467-2. View

3.
Williams 3rd R, Ranawat A, Potter H, Carter T, Warren R . Fresh stored allografts for the treatment of osteochondral defects of the knee. J Bone Joint Surg Am. 2007; 89(4):718-26. DOI: 10.2106/JBJS.F.00625. View

4.
Bhattarai S, Bhattarai N, Viswanathamurthi P, Yi H, Hwang P, Kim H . Hydrophilic nanofibrous structure of polylactide; fabrication and cell affinity. J Biomed Mater Res A. 2006; 78(2):247-57. DOI: 10.1002/jbm.a.30695. View

5.
Gannon F, Sokoloff L . Histomorphometry of the aging human patella: histologic criteria and controls. Osteoarthritis Cartilage. 1999; 7(2):173-81. DOI: 10.1053/joca.1998.0206. View